CardioSignal presented data at ESC 2024 annual meeting on atrial fibrillation detection reliability among people suspected of various heart conditions
Posted:
CardioSignal’s CEO, co-founder, and cardiologist Juuso Blomster presented the results in the session: Transforming population health through mobile technology at the European Society of Cardiology (ESC) annual meeting that was being held in London on 30 August - 2 September.
Researchers have begun scanning the first young athletes taking part in a new study using advanced brain imaging to explore the effects of head injuries in 11 to 18-year-olds.
Read more here.
The Swiss company’s over-the-counter wrist wearable, which uses optical sensors to gather blood pressure readings, will be available to U.S. consumers in 2026.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us